These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7662385)

  • 21. [Bepridil--electrophysiologic properties of a new calcium antagonist with an anti-arrhythmia effect].
    Zehender M; Geibel A; Henning B; Hohnloser S; Meinertz T; Just H
    Z Kardiol; 1988 Feb; 77(2):93-8. PubMed ID: 3259053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dispersion of the corrected QT and JT interval in the electrocardiogram of alcoholic patients.
    Corović N; Duraković Z; Misigoj-Duraković M
    Alcohol Clin Exp Res; 2006 Jan; 30(1):150-4. PubMed ID: 16433743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk of arrhythmias in hemodialysis patients vs healthy people].
    Milone F; Urso S; Garozzo M; Memeo AM; Volpe G; Battaglia G
    G Ital Nefrol; 2004; 21 Suppl 30():S241-6. PubMed ID: 15750993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of determination of QT dispersal intervals in anti-arrhythmia therapy].
    Konecná P; Dvorák R; Semrád B
    Vnitr Lek; 1999 Aug; 45(8):453-6. PubMed ID: 11045143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease.
    Lazzerini PE; Capecchi PL; Guideri F; Bellisai F; Selvi E; Acampa M; Costa A; Maggio R; Garcia-Gonzalez E; Bisogno S; Morozzi G; Galeazzi M; Laghi-Pasini F
    Am J Cardiol; 2007 Sep; 100(6):1029-34. PubMed ID: 17826392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ventricular repolarization in diabetic patients: characterization and clinical implications.
    Clemente D; Pereira T; Ribeiro S
    Arq Bras Cardiol; 2012 Nov; 99(5):1015-22. PubMed ID: 23108644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of pranayama (breathing exercise) on arrhythmias in the human heart.
    Dabhade AM; Pawar BH; Ghunage MS; Ghunage VM
    Explore (NY); 2012; 8(1):12-5. PubMed ID: 22225929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QT dispersion and early arrhythmic risk during acute myocardial infarction.
    Ciolli A; Di Lorenzo M; Bevilacqua U; Lo Sardo G; Tripi M; Fidati R; Palamara A
    G Ital Cardiol; 1999 Dec; 29(12):1438-44. PubMed ID: 10687106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
    Milic M; Bao X; Rizos D; Liu F; Ziegler MG
    Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dysrhythmic profile and clinical aspects in a population of 23 patients with hypertrophic cardiomyopathy].
    Catarino C; Lousada N; Serra J; Faria J; Antunes E; Ferreira R; Patrício L; Quininha J; Gracias R; Rato JA
    Rev Port Cardiol; 1991 Jan; 10(1):43-7. PubMed ID: 2059464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of hypertrophic cardiomyopathy].
    Cecchi F; Olivotto I
    G Ital Cardiol; 1999 Oct; 29(10):1199-203. PubMed ID: 10546134
    [No Abstract]   [Full Text] [Related]  

  • 32. Retrospective analysis of the effects of cisapride on the QT interval and QT dispersion in chronic hemodialysis patients.
    Mathis AS; Costeas C; Barone JA
    Am J Kidney Dis; 2001 Dec; 38(6):1284-91. PubMed ID: 11728962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of maximum corrected QT and corrected QT dispersion in electrocardiography after kidney transplantation.
    Monfared A; Ghods AJ
    Iran J Kidney Dis; 2008 Apr; 2(2):95-8. PubMed ID: 19377216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irregular ventricular activation results in QT prolongation and increased QT dispersion: a new insight into the mechanism of AF-induced ventricular arrhythmogenesis.
    Akoum NW; Sanders NA; Wasmund SL; Hamdan MH
    J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1249-52. PubMed ID: 21668564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of arrhythmia in hypertrophic cardiomyopathy].
    Lengfelder W; Senges J
    Dtsch Med Wochenschr; 1991 Sep; 116(36):1359-61. PubMed ID: 1679389
    [No Abstract]   [Full Text] [Related]  

  • 36. [Arrhythmic syndrome and sudden death in hypertrophic cardiomyopathy].
    Storozhakov GI; Selivanov AI; Kisliak OA
    Ter Arkh; 1988; 60(8):137-41. PubMed ID: 2906486
    [No Abstract]   [Full Text] [Related]  

  • 37. [Characteristics of action of various drugs blocking atrioventricular conduction (beta-blockers, verapamil, diltiazem) in constant fibrillation tachyarrhythmia. Is monotherapy optimal?].
    Blagova OV; Nedostup AV
    Ter Arkh; 2006; 78(8):30-8. PubMed ID: 17078214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinant of QT dispersion in patients with hypertrophic cardiomyopathy.
    Kawasaki T; Azuma A; Kuribayashi T; Shiraishi H; Sawada T; Sugihara H; Nakagawa M
    Pacing Clin Electrophysiol; 2003 Apr; 26(4 Pt 1):819-26. PubMed ID: 12715841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome.
    Priori SG; Napolitano C; Diehl L; Schwartz PJ
    Circulation; 1994 Apr; 89(4):1681-9. PubMed ID: 7908611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The imprecision in heart rate correction may lead to artificial observations of drug induced QT interval changes.
    Malik M
    Pacing Clin Electrophysiol; 2002 Feb; 25(2):209-16. PubMed ID: 11915990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.